Vaccine candidate targeting SARS-CoV-2 nucleocapsid protein elicits protective immune response in animal model

By | May 3, 2021
New preclinical results from a study led by David Masopust of the University of Minnesota in Minneapolis, USA, show that a Had5-based vaccine targeting the nucleocapsid protein can also elicit a protective immune response.